These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28346967)

  • 1. Anticoagulation Therapy in Children.
    Radulescu VC
    Semin Thromb Hemost; 2017 Nov; 43(8):877-885. PubMed ID: 28346967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.
    Comerota AJ; Ramacciotti E
    Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities.
    Goldenberg NA; Takemoto CM; Yee DL; Kittelson JM; Massicotte MP
    Blood; 2015 Dec; 126(24):2541-7. PubMed ID: 26500341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefits of preventing venous thromboembolic events.
    Cohen AT
    Curr Med Res Opin; 2012 Jun; 28(6):877-89. PubMed ID: 22533680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G; Becattini C; Franco L
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulants: Novel Approach for the Treatment of Thrombosis in Pediatric Patients?
    Mikler J; Samoš M; Bolek T; Škorňová I; Stančiaková L; Staško J; Mokáň M
    Pediatr Cardiol; 2019 Oct; 40(7):1431-1438. PubMed ID: 31327027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism management: where do novel anticoagulants fit?
    Spyropoulos AC; Turpie AG
    Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New oral anticoagulants for treatment of venous thromboembolism].
    Espinola-Klein C; Weisser G
    Dtsch Med Wochenschr; 2011 Jun; 136(22):1162-4. PubMed ID: 21611919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticoagulants for treatment of venous thromboembolism.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Dec; 23(8):692-5. PubMed ID: 23095463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism.
    Bacchus F; Schulman S
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):513-9. PubMed ID: 25717178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
    Wharin C; Tagalakis V
    Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of dabigatran etexilate for the treatment of venous thrombosis.
    Feuring M; van Ryn J
    Expert Opin Drug Discov; 2016 Jul; 11(7):717-31. PubMed ID: 27159158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics, pharmacokinetics and clinical efficacy of apixaban in the treatment of thrombosis.
    Zheng SS; Chong JJ; Chong BH
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):575-80. PubMed ID: 26982962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV
    Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anticoagulants for the treatment of venous thromboembolism.
    Fernandes CJ; Alves Júnior JL; Gavilanes F; Prada LF; Morinaga LK; Souza R
    J Bras Pneumol; 2016 Apr; 42(2):146-54. PubMed ID: 27167437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anticoagulants in the treatment of VTE.
    Le Gal G; Mottier D
    Semin Respir Crit Care Med; 2012 Apr; 33(2):191-8. PubMed ID: 22648492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.